Daniel Brennan - Net Worth and Insider Trading
Daniel Brennan Net Worth
The estimated net worth of Daniel Brennan is at least $0 dollars as of 2024-04-27. Daniel Brennan is the Exec VP & Chf Operations Off. of Insys Therapeutics Inc and owns about 1 shares of Insys Therapeutics Inc (INSYQ) stock worth over $0. Details can be seen in Daniel Brennan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel Brennan has not made any transactions after 2016-08-09 and currently still holds the listed stock(s).
Transaction Summary of Daniel Brennan
Daniel Brennan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Brennan owns 3 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) , PDS Biotechnology Corp (PDSB) , and Insys Therapeutics Inc (INSYQ) .
Click here to see the complete history of Daniel Brennan’s form 4 insider trades.
Insider Ownership Summary of Daniel Brennan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2018-06-13 | Chief Commercial Officer |
| PDSB | PDS Biotechnology Corp | 2016-10-17 | Chief Operating Officer |
| INSYQ | Insys Therapeutics Inc | 2016-08-09 | Exec VP & Chf Operations Off. |
Daniel Brennan Latest Holdings Summary
Daniel Brennan currently owns a total of 1 stock. Daniel Brennan owns 1 shares of Insys Therapeutics Inc (INSYQ) as of August 9, 2016, with a value of $0.
Latest Holdings of Daniel Brennan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INSYQ | Insys Therapeutics Inc | 2016-08-09 | 1 | 0.04 | 0 |
Holding Weightings of Daniel Brennan
Daniel Brennan Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Brennan has made a total of 0 transactions in Insys Therapeutics Inc (INSYQ) over the past 5 years. The most-recent trade in Insys Therapeutics Inc is the sale of 5,781 shares on August 9, 2016, which brought Daniel Brennan around $110,764.
Insider Trading History of Daniel Brennan
- 1
Daniel Brennan Trading Performance
Daniel Brennan Ownership Network
Ownership Network List of Daniel Brennan
Ownership Network Relation of Daniel Brennan
Daniel Brennan Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Daniel Brennan is the Chief Commercial Officer of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Compliance/Legal Officer Brian Elsbernd , Chief Accounting Officer Alicia Grande , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Daniel Brennan made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 430,000 shares made by Alicia Grande , a net sale of 105,000 shares made by David S Tierney , and a net sale of 89,666 shares made by Brian Elsbernd .
In summary, during the past 3 months, insiders sold 50,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 1,804,523 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,804,523 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Daniel Brennan Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Brennan. You might contact Daniel Brennan via mailing address: C/o Insys Therapeutics, Inc, 1333 South Spectrum Blvd, Suite 100, Chandler Az 85286.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
